This report provides a comprehensive analysis of the global targeted chemotherapy drugs market, examining its trajectory from 2025 through 2032. The study explores key product types, including monoclonal antibodies and angiogenesis inhibitors, alongside applications for treating breast, lung, and gastric cancers. By evaluating regional dynamics across the Americas, APAC, and Europe, the research highlights emerging opportunities and competitive strategies of major players like Roche and Bristol-Myers Squibb in the advancing precision medicine landscape.

Market Overview

The global Targeted Chemotherapy Drugs market is projected to experience significant growth from 2025 through 2032, maintaining a steady compound annual growth rate throughout the forecast period.

Targeted Chemotherapy Drugs represent a specialized class of medications engineered to specifically target and attack cancer cells while minimizing impact on normal cells. These drugs function by identifying and interfering with specific molecules essential to the growth, progression, and spread of cancer. As a form of precision medicine, they aim to align a patient’s individual genetic profile with the most appropriate targeted therapy.

Regional Market Analysis

• United States: The market for Targeted Chemotherapy Drugs in the United States is estimated to increase steadily from 2025 through 2032.
• China: The market for Targeted Chemotherapy Drugs in China is estimated to see growth from 2025 through 2032.
• Europe: The market for Targeted Chemotherapy Drugs in Europe is estimated to expand from 2025 through 2032.

Market Segmentation

By Type

• Monoclonal Antibodies (MABs)
• Cancer Growth Blockers
• Angiogenesis Inhibitors
• PARP Inhibitors

By Application

• Breast Cancer Treatment
• Lung Cancer Treatment
• Gastric Cancer Treatment
• Others

By Region

• Americas: United States, Canada, Mexico, Brazil
• APAC: China, Japan, Korea, Southeast Asia, India, Australia
• Europe: Germany, France, UK, Italy, Russia
• Middle East & Africa: Egypt, South Africa, Israel, Turkey, GCC Countries

Competitive Landscape

Key Players

The following companies have been profiled based on primary expert input and analysis of their market coverage, product portfolios, and market penetration:

• Roche
• Celgene
• Bristol-Myers Squibb
• Takeda
• Seekyo

Market Concentration

In 2025, the two largest global companies in the Targeted Chemotherapy Drugs sector held a significant portion of the total market revenue share.

Report Scope and Methodology

Research Overview

LP Information, Inc. (LPI) 's newest research report, the “Targeted Chemotherapy Drugs Industry Forecast,” reviews total global Targeted Chemotherapy Drugs sales in 2025. It provides a comprehensive analysis of projected sales for the period of 2026 through 2032, broken down by region, market sector, and sub-sector in US$ millions.

Analytical Depth

This Insight Report provides a comprehensive analysis of the global Targeted Chemotherapy Drugs landscape, highlighting key trends related to:

• Product segmentation
• Company formation
• Revenue and market share
• Latest developments
• M&A activity

The report further analyzes the strategies of leading global companies, focusing on their Targeted Chemotherapy Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints to understand their unique positions in an accelerating global market.

Market Drivers and Forecasts

The report evaluates key market trends, drivers, and affecting factors shaping the global outlook. It breaks down the forecast by Type, Application, geography, and market size to highlight emerging pockets of opportunity. Utilizing a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study offers a nuanced view of the current state and future trajectory of the global industry.

Key Questions Addressed

• What is the 10-year outlook for the global Targeted Chemotherapy Drugs market?
• What factors are driving Targeted Chemotherapy Drugs market growth, globally and by region?
• Which technologies are poised for the fastest growth by market and region?
• How do Targeted Chemotherapy Drugs market opportunities vary by end market size?
• How does Targeted Chemotherapy Drugs break out by Type and by Application?

• 1 Scope of the Report

  • 1.1 Market Introduction

  • 1.2 Years Considered

  • 1.3 Research Objectives

  • 1.4 Market Research Methodology

  • 1.5 Research Process and Data Source

  • 1.6 Economic Indicators

  • 1.7 Currency Considered

  • 1.8 Market Estimation Caveats

• 2 Executive Summary

  • 2.1 World Market Overview

    • 2.1.1 Global Targeted Chemotherapy Drugs Annual Sales 2021-2032

    • 2.1.2 World Current & Future Analysis for Targeted Chemotherapy Drugs by Geographic Region, 2021, 2025 & 2032

    • 2.1.3 World Current & Future Analysis for Targeted Chemotherapy Drugs by Country/Region, 2021, 2025 & 2032

  • 2.2 Targeted Chemotherapy Drugs Segment by Type

    • 2.2.1 Monoclonal Antibodies (MABs)

    • 2.2.2 Cancer Growth Blockers

    • 2.2.3 Angiogenesis Inhibitors

    • 2.2.4 PARP Inhibitors

    • 2.2.5 Targeted Chemotherapy Drugs Sales by Type

      • 2.2.5.1 Global Targeted Chemotherapy Drugs Sales Market Share by Type (2021-2026)
      • 2.2.5.2 Global Targeted Chemotherapy Drugs Revenue and Market Share by Type (2021-2026)
      • 2.2.5.3 Global Targeted Chemotherapy Drugs Sale Price by Type (2021-2026)

  • 2.3 Targeted Chemotherapy Drugs Segment by Application

    • 2.3.1 Breast Cancer Treatment

    • 2.3.2 Lung Cancer Treatment

    • 2.3.3 Gastric Cancer Treatment

    • 2.3.4 Others

    • 2.3.5 Targeted Chemotherapy Drugs Sales by Application

      • 2.3.5.1 Global Targeted Chemotherapy Drugs Sale Market Share by Application (2021-2026)
      • 2.3.5.2 Global Targeted Chemotherapy Drugs Revenue and Market Share by Application (2021-2026)
      • 2.3.5.3 Global Targeted Chemotherapy Drugs Sale Price by Application (2021-2026)

• 3 Global by Company

  • 3.1 Global Targeted Chemotherapy Drugs Breakdown Data by Company

    • 3.1.1 Global Targeted Chemotherapy Drugs Annual Sales by Company (2021-2026)

    • 3.1.2 Global Targeted Chemotherapy Drugs Sales Market Share by Company (2021-2026)

  • 3.2 Global Targeted Chemotherapy Drugs Annual Revenue by Company (2021-2026)

    • 3.2.1 Global Targeted Chemotherapy Drugs Revenue by Company (2021-2026)

    • 3.2.2 Global Targeted Chemotherapy Drugs Revenue Market Share by Company (2021-2026)

  • 3.3 Global Targeted Chemotherapy Drugs Sale Price by Company

  • 3.4 Key Manufacturers Targeted Chemotherapy Drugs Producing Area Distribution, Sales Area, Product Type

    • 3.4.1 Key Manufacturers Targeted Chemotherapy Drugs Product Location Distribution

    • 3.4.2 Players Targeted Chemotherapy Drugs Products Offered

  • 3.5 Market Concentration Rate Analysis

    • 3.5.1 Competition Landscape Analysis

    • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)

  • 3.6 New Products and Potential Entrants

  • 3.7 Market M&A Activity & Strategy

• 4 World Historic Review for Targeted Chemotherapy Drugs by Geographic Region

  • 4.1 World Historic Targeted Chemotherapy Drugs Market Size by Geographic Region (2021-2026)

    • 4.1.1 Global Targeted Chemotherapy Drugs Annual Sales by Geographic Region (2021-2026)

    • 4.1.2 Global Targeted Chemotherapy Drugs Annual Revenue by Geographic Region (2021-2026)

  • 4.2 World Historic Targeted Chemotherapy Drugs Market Size by Country/Region (2021-2026)

    • 4.2.1 Global Targeted Chemotherapy Drugs Annual Sales by Country/Region (2021-2026)

    • 4.2.2 Global Targeted Chemotherapy Drugs Annual Revenue by Country/Region (2021-2026)

  • 4.3 Americas Targeted Chemotherapy Drugs Sales Growth

  • 4.4 APAC Targeted Chemotherapy Drugs Sales Growth

  • 4.5 Europe Targeted Chemotherapy Drugs Sales Growth

  • 4.6 Middle East & Africa Targeted Chemotherapy Drugs Sales Growth

• 5 Americas

  • 5.1 Americas Targeted Chemotherapy Drugs Sales by Country

    • 5.1.1 Americas Targeted Chemotherapy Drugs Sales by Country (2021-2026)

    • 5.1.2 Americas Targeted Chemotherapy Drugs Revenue by Country (2021-2026)

  • 5.2 Americas Targeted Chemotherapy Drugs Sales by Type (2021-2026)

  • 5.3 Americas Targeted Chemotherapy Drugs Sales by Application (2021-2026)

  • 5.4 United States

  • 5.5 Canada

  • 5.6 Mexico

  • 5.7 Brazil

• 6 APAC

  • 6.1 APAC Targeted Chemotherapy Drugs Sales by Region

    • 6.1.1 APAC Targeted Chemotherapy Drugs Sales by Region (2021-2026)

    • 6.1.2 APAC Targeted Chemotherapy Drugs Revenue by Region (2021-2026)

  • 6.2 APAC Targeted Chemotherapy Drugs Sales by Type (2021-2026)

  • 6.3 APAC Targeted Chemotherapy Drugs Sales by Application (2021-2026)

  • 6.4 China

  • 6.5 Japan

  • 6.6 South Korea

  • 6.7 Southeast Asia

  • 6.8 India

  • 6.9 Australia

  • 6.10 China Taiwan

• 7 Europe

  • 7.1 Europe Targeted Chemotherapy Drugs by Country

    • 7.1.1 Europe Targeted Chemotherapy Drugs Sales by Country (2021-2026)

    • 7.1.2 Europe Targeted Chemotherapy Drugs Revenue by Country (2021-2026)

  • 7.2 Europe Targeted Chemotherapy Drugs Sales by Type (2021-2026)

  • 7.3 Europe Targeted Chemotherapy Drugs Sales by Application (2021-2026)

  • 7.4 Germany

  • 7.5 France

  • 7.6 UK

  • 7.7 Italy

  • 7.8 Russia

• 8 Middle East & Africa

  • 8.1 Middle East & Africa Targeted Chemotherapy Drugs by Country

    • 8.1.1 Middle East & Africa Targeted Chemotherapy Drugs Sales by Country (2021-2026)

    • 8.1.2 Middle East & Africa Targeted Chemotherapy Drugs Revenue by Country (2021-2026)

  • 8.2 Middle East & Africa Targeted Chemotherapy Drugs Sales by Type (2021-2026)

  • 8.3 Middle East & Africa Targeted Chemotherapy Drugs Sales by Application (2021-2026)

  • 8.4 Egypt

  • 8.5 South Africa

  • 8.6 Israel

  • 8.7 Turkey

  • 8.8 GCC Countries

• 9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities

  • 9.2 Market Challenges & Risks

  • 9.3 Industry Trends

• 10 Manufacturing Cost Structure Analysis

  • 10.1 Raw Material and Suppliers

  • 10.2 Manufacturing Cost Structure Analysis of Targeted Chemotherapy Drugs

  • 10.3 Manufacturing Process Analysis of Targeted Chemotherapy Drugs

  • 10.4 Industry Chain Structure of Targeted Chemotherapy Drugs

• 11 Marketing, Distributors and Customer

  • 11.1 Sales Channel

    • 11.1.1 Direct Channels

    • 11.1.2 Indirect Channels

  • 11.2 Targeted Chemotherapy Drugs Distributors

  • 11.3 Targeted Chemotherapy Drugs Customer

• 12 World Forecast Review for Targeted Chemotherapy Drugs by Geographic Region

  • 12.1 Global Targeted Chemotherapy Drugs Market Size Forecast by Region

    • 12.1.1 Global Targeted Chemotherapy Drugs Forecast by Region (2027-2032)

    • 12.1.2 Global Targeted Chemotherapy Drugs Annual Revenue Forecast by Region (2027-2032)

  • 12.2 Americas Forecast by Country (2027-2032)

  • 12.3 APAC Forecast by Region (2027-2032)

  • 12.4 Europe Forecast by Country (2027-2032)

  • 12.5 Middle East & Africa Forecast by Country (2027-2032)

  • 12.6 Global Targeted Chemotherapy Drugs Forecast by Type (2027-2032)

  • 12.7 Global Targeted Chemotherapy Drugs Forecast by Application (2027-2032)

• 13 Key Players Analysis

  • 13.1 Roche

    • 13.1.1 Roche Company Information

    • 13.1.2 Roche Targeted Chemotherapy Drugs Product Portfolios and Specifications

    • 13.1.3 Roche Targeted Chemotherapy Drugs Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.1.4 Roche Main Business Overview

    • 13.1.5 Roche Latest Developments

  • 13.2 Celgene

    • 13.2.1 Celgene Company Information

    • 13.2.2 Celgene Targeted Chemotherapy Drugs Product Portfolios and Specifications

    • 13.2.3 Celgene Targeted Chemotherapy Drugs Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.2.4 Celgene Main Business Overview

    • 13.2.5 Celgene Latest Developments

  • 13.3 Bristol-Myers Squibb

    • 13.3.1 Bristol-Myers Squibb Company Information

    • 13.3.2 Bristol-Myers Squibb Targeted Chemotherapy Drugs Product Portfolios and Specifications

    • 13.3.3 Bristol-Myers Squibb Targeted Chemotherapy Drugs Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.3.4 Bristol-Myers Squibb Main Business Overview

    • 13.3.5 Bristol-Myers Squibb Latest Developments

  • 13.4 Takeda

    • 13.4.1 Takeda Company Information

    • 13.4.2 Takeda Targeted Chemotherapy Drugs Product Portfolios and Specifications

    • 13.4.3 Takeda Targeted Chemotherapy Drugs Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.4.4 Takeda Main Business Overview

    • 13.4.5 Takeda Latest Developments

  • 13.5 Seekyo

    • 13.5.1 Seekyo Company Information

    • 13.5.2 Seekyo Targeted Chemotherapy Drugs Product Portfolios and Specifications

    • 13.5.3 Seekyo Targeted Chemotherapy Drugs Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.5.4 Seekyo Main Business Overview

    • 13.5.5 Seekyo Latest Developments

• 14 Research Findings and Conclusion